While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...
The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...
Evommune went public late last year and is taking on stiff competition in immunology with a recent mid-stage clinical win.
The Chosun Ilbo on MSN
KOSDAQ biotech stocks swing on analyst remarks
Alteogen, Sam Chun Dang Pharm, and other top market-cap biotech giants on KOSDAQ have been severely shaken by a single ...
Ysios Capital launched a €100M fund to spin out biotech companies from academic research, targeting at least three new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results